Mark Lawrence Rubinstein - 01 Jan 2026 Form 3 Insider Report for ACHIEVE LIFE SCIENCES, INC. (ACHV)

Role
Chief Medical Officer
Signature
/s/ Sandra Thomson as attorney-in-fact for Mark Rubinstein
Issuer symbol
ACHV
Transactions as of
01 Jan 2026
Net transactions value
$0
Form type
3
Filing time
12 Jan 2026, 08:10:03 UTC
Previous filing
30 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rubinstein Mark Lawrence Chief Medical Officer 22722 29TH DR. SE, SUITE 100, BOTHELL /s/ Sandra Thomson as attorney-in-fact for Mark Rubinstein 12 Jan 2026 0002103809

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ACHV Common Stock 39,600 01 Jan 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ACHV Stock Option (right to buy) 01 Jan 2026 Common Stock 47,000 $4.52 Direct F1
holding ACHV Stock Option (right to buy) 01 Jan 2026 Common Stock 50,000 $3.10 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the options became exercisable on September 30, 2025 and the remainder vest in thirty-six equal monthly installments thereafter.
F2 25% of the options become exercisable on October 7, 2026 and the remainder vest in thirty-six equal monthly installments thereafter.